Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Preferred Dividend Payments (2020 - 2021)

Historic Preferred Dividend Payments for Cytek Biosciences (CTKB) over the last 2 years, with Q4 2021 value amounting to -$1.2 million.

  • Cytek Biosciences' Preferred Dividend Payments fell 10435.21% to -$1.2 million in Q4 2021 from the same period last year, while for Dec 2022 it was -$1.2 million, marking a year-over-year decrease of 10398.07%. This contributed to the annual value of $3.0 million for FY2021, which is 8146.96% down from last year.
  • As of Q4 2021, Cytek Biosciences' Preferred Dividend Payments stood at -$1.2 million, which was down 10435.21% from $1.1 million recorded in Q3 2021.
  • Over the past 5 years, Cytek Biosciences' Preferred Dividend Payments peaked at $27.4 million during Q4 2020, and registered a low of -$6.2 million during Q2 2020.